Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
rAAV2-CB-hRPE65 / AGTC
NCT04731883: RPE65 Gene Therapy （LX101）for Leber's Congenital Amaurosis	Not yet recruiting	N/A	9	RoW	Gene therapy-LX1010(AAV2-RPE65), Gene treatment arm	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Leber Congenital Amaurosis	12/22	06/23
NCT06024057: An Expanded Clinical Study Evaluating the AAV2-RPE65 Gene Therapy(LX101) in Patients With LCA	Not yet recruiting	N/A	3	NA	LX101	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)	09/28	09/38